Mennini, F. S., M. Paoletti, C. Bini, A. Marcellusi, M. Falcone, and M. Andreoni. “Cost-Utility Analysis of ceftolozane/Tazobactam Vs Meropenem in Patients With Hospital-Acquired Pneumonia (HABP) or Ventilator-Associated Pneumonia (VABP)”. Global and Regional Health Technology Assessment, vol. 9, no. 1, Apr. 2022, pp. 45-57, doi:10.33393/grhta.2022.2287.